NCT00123656View on ClinicalTrials.gov

Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Esophagitis
Interventions
DRUG

esomeprazole

esomeprazole dosed qam for 8 weeks

DRUG

fluticasone

fluticasone dosed 220 mcg 2 puffs swallowed BID for 8 weeks

Trial Locations (1)

84132

University of Utah HSC, Salt Lake City

All Listed Sponsors
collaborator

American Society for Gastrointestinal Endoscopy

OTHER

lead

University of Utah

OTHER

NCT00123656 - Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis | Biotech Hunter | Biotech Hunter